Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain

Antimicrob Agents Chemother. 2009 Dec;53(12):5288-90. doi: 10.1128/AAC.00822-09. Epub 2009 Sep 21.

Abstract

Two clonally related Pseudomonas aeruginosa isolates, recovered from two patients admitted to a pediatric intensive care unit, were found to harbor a new OXA-2 variant (Asn148Asp), designated OXA-161. The plasmid location of bla(OXA-161) was demonstrated through electroporation to PAO1, and its codification in a class I integron (together with aacA4) was demonstrated through PCR and sequencing. bla(OXA-2) and bla(OXA-161) were cloned in parallel to demonstrate the extended-spectrum beta-lactamase properties of OXA-161, conferring resistance to ceftazidime and reduced susceptibility to cefepime and aztreonam.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amikacin / pharmacology
  • Aminoglycosides / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Cefepime
  • Cephalosporins / pharmacology
  • Clavulanic Acid / pharmacology
  • Gentamicins / pharmacology
  • Humans
  • Imipenem / pharmacology
  • Integrons / genetics*
  • Meropenem
  • Molecular Sequence Data
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / pharmacology
  • Piperacillin / pharmacology
  • Plasmids / genetics*
  • Pseudomonas Infections / microbiology*
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / enzymology*
  • Pseudomonas aeruginosa / genetics*
  • Pseudomonas aeruginosa / isolation & purification
  • Spanien
  • Tazobactam
  • Thienamycins / pharmacology
  • beta-Lactamases / genetics*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Cephalosporins
  • Gentamicins
  • Thienamycins
  • Clavulanic Acid
  • Imipenem
  • Cefepime
  • Amikacin
  • Penicillanic Acid
  • beta-Lactamases
  • Meropenem
  • Tazobactam
  • Piperacillin

Associated data

  • GENBANK/FJ617206
  • GENBANK/GQ202693